RWM
APLT

Raffa Wealth Management’s Applied Therapeutics APLT Stock Holding History

Raffa Wealth Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-189
Closed -$92 – 1107
2025
Q1 		$92 Hold
189
– – ﹤0.01% 1061
2024
Q4 		$162 Buy
+189
New +$1.19K ﹤0.01% 1086

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Raffa Wealth Management's APLT Position: Q2 2025 in Review

Raffa Wealth Management sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 189 shares — an estimated $92 sold.

Raffa Wealth Management first reported a position in APLT in Q4 2024 and held it in 2 quarters. The position peaked at $162 in Q4 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Raffa Wealth Management reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Raffa Wealth Management sold 189 Applied Therapeutics shares in Q2 2025, an estimated $92.
  • Raffa Wealth Management first reported a position in Applied Therapeutics in Q4 2024 and held it in 2 quarters.
  • Raffa Wealth Management's Applied Therapeutics position peaked at $162 in Q4 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Raffa Wealth Management's 13F filing for Q2 2025, filed 27 Jul 2026.